Inovio Tumbles After Analyst Warning Ahead of Vaccine Data

(Bloomberg) -- Inovio Pharmaceuticals Inc. dropped as much as 21% after a Stifel analyst cut his rating following a nine-fold increase, driven in part by day traders’ enthusiasm for small-cap Covid...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.